Research Use Only

NorexBio
FAQ

Frequently asked questions.

Operational answers about shipping, ordering, payment, and research-use compliance. For product detail and mechanism see the science page; for documentation, testing, and CoA detail see the quality page.

24 questions · last updated 16 May 2026

About Retatrutide

What Retatrutide is, and where it stands now

What is Retatrutide?

Retatrutide (development code LY3437943) is a triple agonist that activates three receptors at once: GLP-1, GIP and glucagon. That mechanism is why it's the most-discussed molecule in the research world, in Eli Lilly's phase 2 trial, published in the New England Journal of Medicine (2023), up to 24.2% weight loss was recorded over 48 weeks, the highest figure documented for any agonist in a clinical trial. NorexBio supplies Retatrutide solely as research material for in vitro laboratory research.

How does Retatrutide work?

By hitting three receptors at once. GLP-1 and GIP act on appetite and insulin signalling, while the glucagon arm raises energy expenditure, a combination no single- or dual-agonist (such as semaglutide or tirzepatide) has. That's why Retatrutide is described as next-generation. This describes published preclinical and clinical data, not claims about NorexBio's research material.

How long does Retatrutide take to work?

In Lilly's phase 2 data, measurable changes appeared within the first weeks, with the effect building across the full 48-week period as the dose was titrated up. That timeline applies to the clinical study population, NorexBio makes no efficacy claims and supplies the material for in vitro laboratory research only.

When is Retatrutide coming to Sweden?

Retatrutide is not yet approved by the EMA or the Swedish Medical Products Agency, it is in phase 3 trials (the TRIUMPH programme) and is not available on prescription in Sweden. What is available today is research material. NorexBio ships pre-filled Retatrutide research pens to Sweden from our German hub within 2–3 days, strictly for in vitro laboratory research.

What side effects does retatrutide have?

In Eli Lilly's clinical trials the most commonly reported side effects were gastrointestinal, nausea, diarrhoea and vomiting, typically dose-dependent and most pronounced during dose escalation, consistent with other incretin-based molecules. This refers to the clinical study population. NorexBio makes no efficacy or safety claims and supplies retatrutide only as research material for in vitro laboratory research.

Shipping & Handling

Dispatch, transit, and storage

Where does NorexBio ship retatrutide from?

NorexBio ships from German stock. Fulfilment operates from EU warehousing rather than dropshipping from overseas suppliers, which reduces transit time and handling steps.

How long does NorexBio retatrutide delivery take in the EU?

Standard delivery across the EU is 2-3 business days from dispatch. Active lots dispatch within 2 business days of payment clearing, so most EU orders complete within a 4-5 business day window from order to delivery.

Does NorexBio ship retatrutide internationally outside the EU?

International shipping outside the EU is handled on a case-by-case basis. Researchers in non-EU jurisdictions should contact the research team before ordering to confirm delivery feasibility and any local research-use restrictions.

How is retatrutide shipped to maintain cold chain?

Each shipment is cold-chain packed with temperature-controlled insulation and includes a temperature-monitoring insert. The monitoring insert lets researchers verify on arrival that the pen remained within specification during transit.

How should retatrutide pens be stored on arrival?

Retatrutide pens should be refrigerated between 2-8°C immediately on arrival and kept refrigerated until use. Storage guidance is included in writing with every shipment.

How long do retatrutide pens stay stable?

Pens are stability-tested for their stated shelf life when stored within the recommended 2-8°C range. Lot-specific stability and expiry data are recorded on the accompanying Certificate of Analysis.

What happens if a retatrutide pen arrives damaged or out of temperature spec?

NorexBio replaces any pen that arrives damaged or shows a temperature deviation outside the specified range. Researchers should photograph the temperature-monitoring insert and affected pen and contact the research team within 48 hours of arrival.

Ordering & Payment

Pricing, payment, and account

How much does a NorexBio retatrutide pen cost?

NorexBio retatrutide pens are priced at €289 per 15 mg pen (currently in stock). The 6 mg pen is €149 and the 30 mg pen is €359, both currently restocking. Pricing is published on the order page and remains consistent across single and multi-pen orders, with bulk and recurring-supply pricing available through distributor enquiries.

What payment methods does NorexBio accept?

Payment is accepted by credit and debit card (Visa, Mastercard), SEPA bank transfer, and cryptocurrency (BTC, ETH, USDT). All payments are encrypted and processed through secure checkout.

Is there a minimum order quantity for retatrutide?

There is no minimum order for standard purchases. Researchers can order a single pen for initial work or scale up as needed. Bulk and recurring-supply terms are available through the distributor enquiry process.

Do you offer discounts for bulk retatrutide orders?

Bulk pricing and recurring-supply discounts are available through distributor enquiries rather than as a self-serve checkout option. Volume, region, and supply cadence are discussed before access is granted.

Can I order retatrutide for a research lab or institution?

Yes. NorexBio supplies independent researchers, research labs, and institutional buyers. Institutional orders can include additional documentation routing through the research team, contact us to confirm requirements before ordering.

How do I create a NorexBio research account?

Research accounts are created through the standard checkout flow when placing a first order. The account stores order history, lot documentation, and tracking for future purchases.

Compliance & Research Use

Regulatory framework and restrictions

Is retatrutide approved for clinical use?

No. Retatrutide is a research peptide and is not approved for human consumption, treatment, diagnosis, or veterinary use anywhere NorexBio ships. NorexBio supplies retatrutide strictly for in vitro laboratory and analytical research.

Is research peptide shipping legal in the EU?

Research peptides supplied for in vitro laboratory and analytical use are legal to ship within the EU under research-use frameworks. NorexBio products are not sold for human consumption, veterinary use, or medical diagnosis, and orders are restricted to laboratory and analytical contexts.

What does NorexBio's research-use-only policy require?

Research-use-only means orders are placed for in vitro laboratory work, product pages avoid clinical positioning, no medical-use claims are made, and documentation requests are routed through the research team. Researchers acknowledge research-use terms before site access.

Does NorexBio make any medical or clinical claims about retatrutide?

No. NorexBio does not make medical, clinical, diagnostic, or treatment claims about retatrutide. Product pages, documentation, and communications are limited to research-use language and laboratory context.

Can I use NorexBio retatrutide for clinical research or human trials?

No. NorexBio retatrutide is research-grade material supplied for in vitro laboratory study and is not appropriate for clinical or human-trial use. Clinical research requires GMP-grade material from regulated sources, which NorexBio does not supply.

Is retatrutide legal in Sweden?

Retatrutide is not an approved medicine in Sweden and may not be sold or used for human treatment. As a research peptide for in vitro laboratory use, it is supplied and shipped within the EU under research-use frameworks. NorexBio's products are not sold for clinical use, veterinary use, or medical diagnosis, and orders are restricted to laboratory and analytical contexts. Anyone seeking an approved treatment should speak with a clinician.

Still have questions?

The research team responds within one business day.

Contact the research teamOrder Retatrutide
Order Retatrutide pen →